For Thailand : 2021 TEIN Winter Workshop

Value of the Information & Strength of the Argument

The video provides valuable information on the rationale and methods for personalized dosimetry in nuclear medicine. It argues convincingly for the shift from empirical fixed-dose strategies to patient-specific approaches, citing clinical studies that demonstrate improved therapeutic responses and manageable toxicity. The argumentation is well-structured, starting with the concept of theranostics, then presenting evidence from thyroid cancer and radioembolization studies, and finally discussing ongoing trials in PRRT. The lectures also address practical challenges, such as the complexity and time required for dosimetry, and propose voxel-based methods as a more efficient solution. Overall, the content is informative and persuasive, though it could benefit from more detailed data and references.

Scientific Rigor, Source Quality, Title Accuracy

The scientific rigor is generally high, as the lectures are delivered by experts and reference key studies and clinical trials (e.g., NETTER-1, ILUMINATE). However, specific citations are not provided in the video, and the sources are not explicitly listed. The title accurately reflects the content, which is a workshop for Thailand and Myanmar on dosimetry. The content is well-organized and technically accurate, but the lack of explicit source citations limits the ability to verify claims independently. The video does not include a public comments section, so no analysis of viewer feedback is possible.

The title accurately reflects the content, which is a workshop for Thailand and Myanmar participants on personalized dosimetry.

7/10

The video is a workshop lecture by experts in nuclear medicine, providing a solid overview of internal dosimetry principles and applications. The content is based on established scientific knowledge and references key studies, but lacks detailed citations and peer-reviewed verification within the video itself.

Markers derived by PSI from the transcript: the creator did not define chapters.

• 00:00Introduction and welcome by Professor Song, overview of theranostics and importance of dosimetry.
• 10:00Discussion on the concept of 'as high as safely administrable' (AHASA) and strategies for personalized dosimetry.
• 20:00Review of clinical studies on thyroid cancer and radioembolization demonstrating benefits of personalized dosimetry.
• 30:00Introduction to PRRT and the NETTER-1 trial, highlighting the fixed-dose approach and the need for personalization.
• 40:00Explanation of organ-based dosimetry, including time-activity curves and S-values.
• 50:00Introduction to voxel-based dosimetry and its advantages over organ-based methods.
• 1:00:00Q&A session addressing practical challenges and the need for user-friendly dosimetry software.

• NETTER-1 trial — Referenced in the context of PRRT and lutetium-177 dotatate approval.
• ILUMINATE trial — Mentioned as a multicenter study on personalized dosimetry in lutetium-177 dotatate therapy.

• MIRD Pamphlet No. 21 — Standard for voxel-based dosimetry methods.